Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios predict tumor size and survival in HCC patients: Retrospective study


SUNER KARAKÜLAH A., Carr B.

ANNALS OF MEDICINE AND SURGERY, vol.58, pp.167-171, 2020 (ESCI) identifier identifier identifier

Abstract

Background: Inflammation is a recognized concomitant of hepatocellular carcinoma (HCC) and its indices are prognostically useful.